Pulmonary Nodular Amyloidosis and Evidence-Based Practice

Introduction

Medical diagnosis is the process of establishing which condition or disease explains the signs and symptoms. A physical exam, health history, and blood tests can help make a diagnosis. On the other hand, evidence-based practice is a problem-solving method to clinical practice that includes the most acceptable proof from preferences, well-designed lessons, patient ideals, and clinician knowledge in decision-making concerning patient maintenance (Drisko & Grady, 2019). An example of a medical diagnosis that could benefit from an evidence-based approach is Pulmonary Nodular Amyloidosis (PNA), a term in medicine meaning inflammation of lungs due to viruses, bacteria, or other pathogens. Symptoms of Pneumonia are difficulty in breathing, cough with pus or phlegm, chills, and fever (Lam & Schubert, 2019). Applying evidence-based to this diagnosis serves to provide nursing quality care and better patient outcome.

Criteria for Determining and Analyzing Credibility of Sources

Finding research sources is essential but using unreliable sources hurts the credibility of an argument, thus making it look baseless. The credibility of sources is determined by depth, which means that information should be more than just a simple overview and about currency; the data should be recent. One critical evaluation criterion in evaluating the credibility of a resource is the purpose (Hocevar et al., 2017). A source can have a variety of purposes: articles, journals, and newspapers provide information, viral videos entertain, and editorials persuade advocates. In this response, one journal addressing Pulmonary Nodular Amyloidosis is ‘Advances in the prevention management and treatment of community-acquired pneumonia’ (Hill, 2020). This is a credible source as it discusses recent major concepts and studies such as the importance and roles of biomarkers, appropriate risk stratification to help to identify patients needing intensive care or hospitalization, and appropriate empiric antibiotic therapy which includes the effects of macrolide combination therapy and stewardship of antibiotics.

Other journals have revealed two types of pneumonia, community-acquired and hospital-acquired pneumonia. ‘Therapeutic Advances in Infectious disease’ is a journal addressing advances in community-acquired pneumonia (Jones & Waterer, 2020). This journal focuses on advances in the care and research of community-acquired pneumonia in the past twenty years. It gives a summary of the evidence around people’s knowledge on diagnosis and pathogenesis. This journal also discusses the key issues of management like the use or non-use of corticosteroids and explores the relationship between long-term outcomes and pneumonia. Through these details, this journal passes the credibility test as it gives more than an overview of information on pneumonia.

Importance of Evidence-Based Practice to Pneumonia

Making a habit of proof based-practice promotes a cooperative approach to care. Hospitals have developed bilingual patient education handouts through an evidence-based approach to help patients in supervising their pneumonia when not in a hospital. These handouts explain that pneumonia recovery takes time and commend taking the specified medication, pursuing medical attention in case of threatening signs like fever, and avoiding tobacco products. Additionally, evidence-based practices are effective in reducing the length of hospital stay, mortality, and core measure compliance without affecting readmissions. Nursing care of community-acquired pneumonia patients has aided healthcare specialists in hospitals in making decisions on effective and appropriate treatment for community-acquired pneumonia patients.

Evidence-Based Nursing Models for Pneumonia Diagnosis

Some evidence-based practices used to address the diagnosis of Pulmonary Nodular Amyloidosis include; Advancing Research and Clinical practice through a close Collaboration (ARCC) ideal, ACC Model, and Stetler Model. Focusing on ARCC Model, it uses five steps to achieve positive outcomes in Pulmonary Nodular Amyloidosis care (Little et al., 2017). The first step is the assessment of institutional readiness in the system of healthcare. Secondly, identifying strengths and barriers of evidence-based practice in the institution. Potential barriers to the implementation of this model are lack of evidence-based valuing and insufficient evidence-based skills and knowledge.

On the other hand, the strengths include the presence of evidence-based champions and administrative support. The third step is identifying evidence-based practice mentors who facilitate the development of evidence-based journal clubs. Presence of mentors also constitutes the fourth stage; implementation of evidence-based practice in the organization. Lastly, the hospital evaluates the outcomes resulting from the implementation of the ARCC Model. These outcomes include; satisfaction of the healthcare provider, decreased hospital costs, and improvement in the outcome of Pneumonia patients.

Conclusion

In conclusion, the ability to use evidence-based practice is essential in various settings and with many clients. In medicine, the evidence approach provides scientific research and updates on patient care protocols to nurses. Nurses also assess the research to comprehend the effectiveness and risks of a treatment or diagnostic test. Evidence-based medicine is essential in increasing effective treatments and avoiding ineffective and harmful treatments. The evidence approach is a crucial step in improving the outcome of a client’s professional liability. It also moves social work from a single evaluation outcome into a large-scale based development.

References

Drisko, J. W., & Grady, M. D. (2019). Step 2 of EBP: Locating practice research. Essential clinical social work series, 95-106. Web.

Hill, A. T. (2020). Management of community-acquired pneumonia in immunocompromised adults. Chest, 158(5), 1802-1803. Web.

Hocevar, K. P., Metzger, M., & Flanagin, A. J. (2017). Source credibility, expertise, and trust in health and risk messaging. Oxford research encyclopedia of communication. Web.

Jones, B., & Waterer, G. (2020). Advances in community-acquired pneumonia. Therapeutic advances in infectious disease, 7.

Little, S. H., Dickerson, P. S., Randolph, G., Rocco, P., & Short, N. (2017). Using the ARCC model to implement the 2015 ANCC COA criteria: A North Carolina public health nursing project. The journal of continuing education in nursing, 48(11), 501-507. Web.

Cite this paper

Select style

Reference

NursingBird. (2024, December 7). Pulmonary Nodular Amyloidosis and Evidence-Based Practice. https://nursingbird.com/pulmonary-nodular-amyloidosis-and-evidence-based-practice/

Work Cited

"Pulmonary Nodular Amyloidosis and Evidence-Based Practice." NursingBird, 7 Dec. 2024, nursingbird.com/pulmonary-nodular-amyloidosis-and-evidence-based-practice/.

References

NursingBird. (2024) 'Pulmonary Nodular Amyloidosis and Evidence-Based Practice'. 7 December.

References

NursingBird. 2024. "Pulmonary Nodular Amyloidosis and Evidence-Based Practice." December 7, 2024. https://nursingbird.com/pulmonary-nodular-amyloidosis-and-evidence-based-practice/.

1. NursingBird. "Pulmonary Nodular Amyloidosis and Evidence-Based Practice." December 7, 2024. https://nursingbird.com/pulmonary-nodular-amyloidosis-and-evidence-based-practice/.


Bibliography


NursingBird. "Pulmonary Nodular Amyloidosis and Evidence-Based Practice." December 7, 2024. https://nursingbird.com/pulmonary-nodular-amyloidosis-and-evidence-based-practice/.